HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias.

Abstract
The influence of hormonal oral contraceptives on the urinary porphyrin excretion of 40 healthy females has been studied. Two different hormonal oral contraceptives (combinations of gestoden or desogestrel, respectively, and ethinylestradiol) were applied for half a year. In each case twenty women received one of these two combinations. Porphyrin precursors delta-aminolevulinic acid and porphobilinogen were normal in all subjects as well as the mean of uroporphyrin and coproporphyrin. One healthy female developed a mild secondary coproporphyrinuria. In this case coproporphyrin isomer I was slightly enhanced and isomer III slightly lowered. Furthermore it could be shown that three females with repeated premenstrual clinical expression of an acute hepatic porphyria (acute intermittent porphyria and hereditary coproporphyria) could be treated successfully with a hormonal oral contraceptive or other exogenous hormones to stabilize the latent, subclinical phase of the disease.
AuthorsU Gross, M Honcamp, E Daume, M Frank, B Düsterberg, M O Doss
JournalHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme (Horm Metab Res) Vol. 27 Issue 8 Pg. 379-83 (Aug 1995) ISSN: 0018-5043 [Print] Germany
PMID7590628 (Publication Type: Journal Article)
Chemical References
  • Contraceptives, Oral, Combined
  • Contraceptives, Oral, Hormonal
  • Coproporphyrins
  • Norpregnenes
  • Porphyrins
  • Uroporphyrins
  • Gestodene
  • Ethinyl Estradiol
  • Porphobilinogen
  • Desogestrel
  • Aminolevulinic Acid
Topics
  • Adult
  • Aminolevulinic Acid (urine)
  • Contraceptives, Oral, Combined (therapeutic use)
  • Contraceptives, Oral, Hormonal (therapeutic use)
  • Coproporphyrins (urine)
  • Desogestrel (administration & dosage, therapeutic use)
  • Ethinyl Estradiol (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Norpregnenes (administration & dosage, therapeutic use)
  • Porphobilinogen (urine)
  • Porphyrias (drug therapy, urine)
  • Porphyrias, Hepatic (drug therapy)
  • Porphyrins (urine)
  • Uroporphyrins (urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: